Review and Network Meta-Analysis. PLoS One. 2015;10(12):e0144856. \[[PMC free article: PMC4696796](/pmc/articles/PMC4696796/)\] \[[PubMed: 26716830](https://pubmed.ncbi.nlm.nih.gov/26716830)\] 49. Cohen AT, Hamilton M, Bird A, Mitchell SA, Li S, Horblyuk R, Batson S. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS One. 2016;11(8):e0160064. \[[PMC free article: PMC4972314](/pmc/articles/PMC4972314/)\] \[[PubMed: 27487187](https://pubmed.ncbi.nlm.nih.gov/27487187)\] 50. Rollins BM, Silva MA, Donovan JL, Kanaan AO. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach. Clin Ther. 2014 Oct 01;36(10):1454-64.e3. \[[PubMed: 25092394](https://pubmed.ncbi.nlm.nih.gov/25092394)\] 51. Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, Lo-Ciganic WH. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Clin Ther. 2017 Jul;39(7):1456-1478.e36. \[[PubMed: 28668628](https://pubmed.ncbi.nlm.nih.gov/28668628)\] 52. Root CW, Dudzinski DM, Zakhary B, Friedman OA, Sista AK, Horowitz JM. Multidisciplinary approach to the management of pulmonary embolism patients: the pulmonary embolism response team (PERT). J Multidiscip Healthc. 2018;11:187-195. \[[PMC free article: PMC5896654](/pmc/articles/PMC5896654/)\] \[[PubMed: 29670358](https://pubmed.ncbi.nlm.nih.gov/29670358)\] 53. McCaughan GJB, Favaloro EJ, Pasalic L, Curnow J. Anticoagulation at the extremes of body weight: choices and dosing. Expert Rev Hematol. 2018 Oct;11(10):817-828. \[[PubMed: 30148651](https://pubmed.ncbi.nlm.nih.gov/30148651)\] 54. Fallaha MA, Radha S, Patel S. Safety and efficacy of a new thromboprophylaxis regiment for total knee and total hip replacement: a retrospective cohort study in 265 patients. Patient Saf Surg. 2018;12:22. \[[PMC free article: PMC6090615](/pmc/articles/PMC6090615/)\] \[[PubMed: 30123323](https://pubmed.ncbi.nlm.nih.gov/30123323)\] **Disclosure:** Sheikh Waheed declares no relevant financial relationships with ineligible companies. **Disclosure:** Pujitha Kudaravalli declares no relevant financial relationships with ineligible companies. **Disclosure:** David Hotwagner declares no relevant financial relationships with ineligible companies.